Zellweger SyndromeSymptoms, Doctors, Treatments, Advances & More
Zellweger Syndrome Overview
Learn About Zellweger Syndrome
- Zellweger syndrome
- CHR
- Cerebrohepatorenal syndrome
- ZS
- ZWS
- Zellweger leukodystrophy
Munroe Meyer Institute
William Rizzo is a Medical Genetics provider practicing medicine in Omaha, Nebraska. He has been practicing medicine for over 49 years. Dr. Rizzo is rated as an Elite provider by MediFind in the treatment of Zellweger Syndrome. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Sjogren-Larsson Syndrome, Zellweger Syndrome, Pompe Disease, and Danon Disease.
Nancy Braverman is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Baltimore, Maryland. Dr. Braverman is rated as an Elite provider by MediFind in the treatment of Zellweger Syndrome. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Zellweger Syndrome, Chondrodysplasia Punctata Syndrome, X-Linked Chondrodysplasia Punctata 2, and Acromesomelic Dysplasia.
Hans Waterham practices practicing medicine in Amsterdam, Netherlands. Mr. Waterham is rated as an Elite expert by MediFind in the treatment of Zellweger Syndrome. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Zellweger Syndrome, Refsum Disease, X-Linked Chondrodysplasia Punctata 2, and Chondrodysplasia Punctata Syndrome.
Summary: The goal of this observational study is to define the course of the retinal degeneration in a ZSD patient cohort. The objective of this study is to gather information so the investigators can: 1. define the course of the retinal degeneration in a ZSD patient cohort with retinal degeneration 2. define what tests best monitor the progression of the retinal degeneration 3. generate prognostic informa...
Summary: The Peroxisome Biogenesis Disorders (PBD) are a group of inherited disorders due to defects in peroxisome assembly causing complex developmental and metabolic sequelae. In spite of advancements in peroxisome biology, the pathophysiology remains unknown, the spectrum of phenotypes poorly characterized and the natural history not yet systematically reported. Our aims are to further define this popul...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center
